Favorable Outcome of COVID-19 Pneumonia in a Kidney Transplant Recipient Treated with Tocilizumab
The presentation of COVID-19 pneumonia in kidney transplant recipients is similar to that of the general population. However, in the former, it may have a worse clinical course. We report a kidney transplant patient affected by COVID-19 pneumonia whose condition worsened 9 days after the initial pre...
Saved in:
| Main Authors: | Adnane Guella, Osman Elfadil, Ghisson Abdulrazaq, Sahla Osman, Mohammed Munir Khan, Abdalla Ahmed, Feras Deyab |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Infectious Diseases |
| Online Access: | http://dx.doi.org/10.1155/2020/8830626 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tocilizumab-Based Treatment of Microvascular Inflammation in Kidney Transplant Recipients: A Retrospective Study
by: Johan Noble, et al.
Published: (2025-05-01) -
Favorable outcome of pregnancy in a kidney and pancreas recipient
by: S. V. Romanov, et al.
Published: (2023-03-01) -
Pneumonia in a patient with kidney transplant treated with alirocumab and everolimus
by: Lucía Ordóñez-Fernández, et al.
Published: (2019-03-01) -
Clinical Characteristics, Virulence Profile, and Molecular Epidemiology of Klebsiella pneumoniae Infections in Kidney Transplant Recipients
by: Fan R, et al.
Published: (2025-03-01) -
Nutritional management of kidney transplant recipient
by: Pratim Sengupta, et al.
Published: (2025-03-01)